Legislative Action

HB 40 - State Abortion Insurance / Public Aid Act - ACTION ALERT Status: Passed the House and Senate, now goes to the Governor Sum...

March 1, 2017

"Big Abortion" Wants the Dangerous Pregnancy-Destroying Drug Mifepristone (RU-486) Sold in Local Pharmacies

Dr. Thomas Price, Secretary of the Department of Health and Human Services, please take note. Your U.S. Food and Drug Administration (FDA) will soon be cooperating (conspiring) with abortion activists to relax important health regulations so that America’s only approved abortion regimen can be sold by local drug stores. In fact, the process may well be underway as I write.

Big Abortion’s aggressive push for evermore abortion, despite great health concerns for the mother (not to mention the baby), appears to know few bounds. Mifepristone, also known as RU-486, is incontrovertibly an embryo and fetal-destructive chemical. Mifepristone (also, Mifeprex®) blocks the chemical action of progesterone, the key hormone that drives pregnancy forward. Mifepristone is taken with a second drug, misoprostol (Cytotec), which causes uterine-emptying contractions when taken by a pregnant woman. This two-drug abortion regimen was first approved by the FDA in 2000.

There are many details related to the distribution of this regimen, but the key points to note are that access to the mifepristone itself is still pretty tightly controlled. The current 2016 regulations for the mifepristone regimen do not allow it to be sold in pharmacies. Rather, mifepristone may be distributed only by certified healthcare providers (originally, it had to be a physician). Such providers must have the ability to assess the duration of the pregnancy accurately, be able to diagnose ectopic pregnancies, be able to get the patient to surgical intervention in case of an incomplete abortion or severe bleeding, and, finally, must have read the prescribing information about the regimen. Clearly this sort of patient assessment cannot take place at pharmacies. The regimen may not be prescribed after the 70th day of pregnancy (LMP).